StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 18, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Drugs Made In America Acquisition's operating cash flow for the twelve months ending Jun 30, 2026 was -$517.15K. For fiscal 2025 it was -$539.19K.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$539.19K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$244.61K–
Q1 FY2026Mar 31, 2026-$91.25K–
Q4 FY2025Dec 31, 2025-$125.18K–
Q3 FY2025Sep 30, 2025-$56.11K–
Q2 FY2025Jun 30, 2025-$106.66K–
Q1 FY2025Mar 31, 2025-$251.24K–

More Drugs Made In America Acquisition figures

See a number that looks wrong?